Nasdaq

Lexicon Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Lexicon Pharmaceuticals, Inc. announced that it will release its financial results for the fourth quarter and full year 2024 on March 6, 2025, after market close. Following the release, the company's ...
Nasdaq

Lexicon Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides R&D Updates

THE WOODLANDS, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended September 30, 2025, and provided an ...
Seeking Alpha

Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates

Phase 2b PROGRESS study confirmed 10 mg pilavapadin as appropriate dose for advancement into Phase 3 development for diabetic peripheral neuropathic pain Conference call and webcast at 5:00 pm ET THE ...
Nasdaq

Lexicon Pharmaceuticals Scheduled to Release Q2 2025 Financial Results and Conduct Conference Call on August 6, 2025

Lexicon Pharmaceuticals will release Q2 2025 financial results on August 6, with a conference call scheduled for 8:30 a.m. ET. Lexicon Pharmaceuticals, Inc. announced that it will release its second ...